We have previously outlined the contribution of a number of transcription factors, including p53, c-Myc, and hypoxia-inducing factor (HIF), to prostate cancer progression acting in part by regulating the expression of metabolic enzymes. The gene discussed is MYC; the disease is prostate cancer.